Cyclodextrins and drug permeability through semi-permeable cellophane membranes

被引:67
作者
Loftsson, T [1 ]
Másson, M [1 ]
Sigurdsson, HH [1 ]
机构
[1] Univ Iceland, Fac Pharm, IS-127 Reykjavik, Iceland
关键词
semi-permeable membranes; cyclodextrin; flux; complexation; self-association;
D O I
10.1016/S0378-5173(01)00895-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Determinations of drug fluxes through semi-permeable cellophane membranes are used to evaluate cyclodextrin complexes and cyclodextrin containing drug formulations. In the present study we investigated how the cyclodextrin concentration, the membrane thickness and the molecular weight cut off (MWCO) of the membrane influence drug fluxes. The cyclodextrin used was 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD) and the sample drug was hydrocortisone. The MWCO of the membranes ranged from 500 to 14,000 and the HPbetaCD concentration ranged from 0 to 25% (w/v). The hydrocortisone flux from saturated solutions through the MWCO 500 membrane was unaffected by the cyclodextrin concentration. When MWCO of the membrane was greater than the molecular weight of the complex the flux from solutions saturated with hydrocortisone increased with increasing HPbetaCD concentration. This increase showed negative deviation from linearity. When the flux was corrected for the viscosity increase with increasing HPbetaCD concentration then the flux pattern could be described on the basis of Fick's first law and Stokes-Einstein equation. However. the flux did not correlate with the viscosity when it was increased by adding polymer to the saturated drug solutions. It was shown that the observed flux pattern was consistent with self-association of cyclodextrin complexes in the aqueous donor phase. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:35 / 43
页数:9
相关论文
共 17 条
[1]   Drug-cyclodextrin association constants determined by surface tension and surface pressure measurements -: II.: Sequestration of water insoluble drugs from the air-water interface:: Retinol-β cyclodextrin system [J].
Angelova, A ;
Ringard-Lefebvre, C ;
Baszkin, A .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1999, 212 (02) :280-285
[2]  
Higuchi T., 1965, Interscience, New York, V4, P117
[3]   Pharmaceutical applications of cyclodextrins .3. Toxicological issues and safety evaluation [J].
Irie, T ;
Uekama, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (02) :147-162
[4]   Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-8-cyclodextrin [J].
Jarho, P ;
Urtti, A ;
Pate, DW ;
Suhonen, P ;
Jarvinen, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 137 (02) :209-216
[5]  
Jarho P., 1996, P 8 INT S CYCL, P395
[6]   Cyclodextrins in topical drug formulations: theory and practice [J].
Loftsson, T ;
Masson, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 225 (1-2) :15-30
[7]   Cyclodextrins: new drug delivery systems in dermatology [J].
Loftsson, T ;
Olafsson, JH .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1998, 37 (04) :241-246
[8]   Pharmaceutical applications of cyclodextrins .1. Drug solubilization and stabilization [J].
Loftsson, T ;
Brewster, ME .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (10) :1017-1025
[9]   Cyclodextrins in ophthalmic drug delivery [J].
Loftssona, T ;
Järvinen, T .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) :59-79
[10]   Cyclodextrins as permeation enhancers:: some theoretical evaluations and in vitro testing [J].
Másson, M ;
Loftsson, T ;
Másson, G ;
Stefánsson, E .
JOURNAL OF CONTROLLED RELEASE, 1999, 59 (01) :107-118